Atherogenesis is characterized by a proliferation of arterial smooth m
uscle cells that may be of transformed nature. Platelets are implicate
d in the progression of atherosclerotic lesions through thrombotic com
plications. The present study was designed to investigate whether tran
sformed arterial smooth muscle cells (SMC) could specifically aggregat
e platelets. We used rat transformed arterial SMC lines, V6- and V8-li
nes, that we bad previously established. Experiments were performed wi
th an in vitro homologous rat system. Suspensions of SMC were added wi
thout any other aggregating agent to rat heparinized platelet-rich pla
sma (PRP) in a coagulo-aggregometer. The effect of transformed V6-line
and V8-line SMC was compared to that of their normal parental counter
parts, V6- and Vs-parent cells. Suspensions of transformed SMC induced
, in a dose-dependent manner, an immediate and reversible ADP-like pla
telet aggregation. The amplitude of platelet aggregation was much high
er with addition of transformed cells than of the corresponding contro
l SMC (7.39 +/- 0.75 cm vs. 0.85 +/- 0.62 cm with 2 x 10(6) SMC, V6-li
ne vs. V6-parent cells, respectively). ADP-like aggregation did not si
gnificantly differ between the two transformed V6- and Vs-lines. ADP-l
ike platelet aggregation was also obtained with supernatants of transf
ormed SMC suspensions, the amplitude being higher with supernatants th
an with cell suspensions (21.0 +/- 3.64 cm vs. 6.8 +/- 1.22 cm with 1.
0 x 10(6) V8-line cells, supernatant vs, cell suspension, respectively
). The transformed SMC-induced aggregation of platelets was inhibited
by apyrase (125 mu M) and iodoacetate (25mM) and thus was ascribable t
o ADP released by the SMC. In addition, all suspensions of SMC, normal
or transformed, but not their supernatants, induced plasma clotting a
fter variable coagulation times. Coagulation was inhibited by hirudin
(25 to 100 U/ml) and phospholipase A2 (10 U/ml) indicating thrombin ge
neration through activity of the SMC membrane tissue factor. The prese
nt results show that transformed arterial smooth muscle cells may dire
ctly aggregate platelets via a release of ADP and this could be of pat
hophysiological relevance for thrombosis associated with atheroscleros
is.